Kant A, van Hunsel F. Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands". Drug Saf 2022;45:925-926.
PMID: 35838877